176 related articles for article (PubMed ID: 28207798)
21. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
22. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model.
Hasebe T; Tanaka H; Sawada K; Nakajima S; Ohtake T; Fujiya M; Kohgo Y
J Gastroenterol; 2017 Mar; 52(3):341-351. PubMed ID: 27364348
[TBL] [Abstract][Full Text] [Related]
24. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
[TBL] [Abstract][Full Text] [Related]
25. A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models.
Kawata Y; Okuda S; Hotta N; Igawa H; Takahashi M; Ikoma M; Kasai S; Ando A; Satomi Y; Nishida M; Nakayama M; Yamamoto S; Nagisa Y; Takekawa S
Eur J Pharmacol; 2017 Feb; 796():45-53. PubMed ID: 27986627
[TBL] [Abstract][Full Text] [Related]
26. LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity.
Miranda DA; Krause WC; Cazenave-Gassiot A; Suzawa M; Escusa H; Foo JC; Shihadih DS; Stahl A; Fitch M; Nyangau E; Hellerstein M; Wenk MR; Silver DL; Ingraham HA
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515023
[TBL] [Abstract][Full Text] [Related]
27. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
28. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
29. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
30. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
32. MC4R deficiency in pigs results in hyperphagia and ultimately hepatic steatosis without high-fat diet.
Hao H; Lin R; Li Z; Shi W; Huang T; Niu J; Han J; Li Q
Biochem Biophys Res Commun; 2019 Dec; 520(3):651-656. PubMed ID: 31629472
[TBL] [Abstract][Full Text] [Related]
33. Peroxisomes compensate hepatic lipid overflow in mice with fatty liver.
Knebel B; Hartwig S; Haas J; Lehr S; Goeddeke S; Susanto F; Bohne L; Jacob S; Koellmer C; Nitzgen U; Müller-Wieland D; Kotzka J
Biochim Biophys Acta; 2015 Jul; 1851(7):965-76. PubMed ID: 25790917
[TBL] [Abstract][Full Text] [Related]
34. Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis.
Liu Y; Jiang L; Sun C; Ireland N; Shah YM; Liu Y; Rui L
Nat Commun; 2018 Jul; 9(1):2751. PubMed ID: 30013137
[TBL] [Abstract][Full Text] [Related]
35. High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD.
Konstantynowicz-Nowicka K; Berk K; Chabowski A; Kasacka I; Bielawiec P; Łukaszuk B; Harasim-Symbor E
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387306
[TBL] [Abstract][Full Text] [Related]
36. JIP3 knockout protects mice against high fat diet-induced liver injury.
Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
[TBL] [Abstract][Full Text] [Related]
37. Divergent Role of Estrogen-Related Receptor α in Lipid- and Fasting-Induced Hepatic Steatosis in Mice.
B'chir W; Dufour CR; Ouellet C; Yan M; Tam IS; Andrzejewski S; Xia H; Nabata K; St-Pierre J; Giguère V
Endocrinology; 2018 May; 159(5):2153-2164. PubMed ID: 29635284
[TBL] [Abstract][Full Text] [Related]
38. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
Zhang L; Yang B; Yu B
Biol Pharm Bull; 2015; 38(7):1005-11. PubMed ID: 25972092
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.
Wu H; Jin M; Han D; Zhou M; Mei X; Guan Y; Liu C
Biochem Biophys Res Commun; 2015 Mar; 458(4):862-8. PubMed ID: 25701781
[TBL] [Abstract][Full Text] [Related]
40. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
